Better Blood Transfusion

Safe and Appropriate Use of Blood
Summary
This Health Service Circular (HSC) replaces HSC 2002/009 Better Blood Transfusion -Appropriate Use of Blood and sets out a new programme of action for the NHS to:
• Build on the success of previous Better Blood Transfusion initiatives to further improve the safety and effectiveness of transfusion • Ensure that Better Blood Transfusion is an integral part of NHS care • As part of clinical governance responsibilities, make blood transfusion safer • Avoid the unnecessary use of blood and blood components (fresh frozen plasma and platelets) in medical and surgical practice • Avoid unnecessary blood transfusion in obstetric practice and minimise the risk of haemolytic disease of the newborn (HDN) • Increase patient and public involvement in blood transfusion
The programme of action should be considered in conjunction with Annex A of this circular that provides further detail on its implementation.
A toolkit to assist NHS Trusts in the implementation of Better Blood Transfusion was developed on the www.transfusionguidelines.org.uk website in 2003. It provides access to national guidance, examples of good practice and patient leaflets, and it will now be updated.
Rationale
The safe and appropriate use of donor blood and alternatives to donor blood are important public health and clinical governance issues:
• Appropriate blood transfusion is an essential support to many clinical treatments and may be life-saving.
• Donated blood is a limited resource. Blood supplies may be reduced as a result of further measures that may have to be taken to reduce the risk of transmission of vCJD by blood transfusion, such as the introduction of a screening test and further restrictions on the eligibility of blood donors.
• The safety of blood transfusion is highlighted yearly through the Serious Hazards of Transfusion (SHOT) scheme (a confidential enquiry for the reporting of serious complications of blood transfusion and near miss events in the UK). This scheme has shown that avoidable, serious hazards of blood transfusion, although decreasing, continue to occur. The incidence of ABOincompatible red cell transfusions appears to be reducing, most likely due to greater attention to detail during the transfusion process including the pretransfusion bedside check, but there are still too many "incorrect blood component transfused" errors and further measures need to be taken by NHS Trusts, including the implementation of the recommendations in the National Patient Safety Agency (NPSA) Safer Practice Notice (SPN) Right PatientRight Blood -www.npsa.nhs.uk/site/media/documents/2009_0316FEB06_V20_WEB.pdf. This SPN emphasises the importance of the final pre-transfusion bedside check, and the need for NHS Trusts to consider the use of information technology to improve transfusion safety and ensure that all relevant staff are trained and undergo regular competency assessment.
• There is continued wide variation in the use of blood despite the existence of national and local clinical guidelines on its appropriate use. There has been good progress in reducing the use of red cell transfusions (around 16% in the last 5 years). This is mainly due to a reduction in blood use in surgery, and similar efforts are now needed in other clinical specialties, in particular medicine which now accounts for over 60% of red cell usage. Similar reductions in usage have not been seen with fresh frozen plasma or platelet transfusions, and efforts are needed to avoid inappropriate usage of these blood components.
• Attention should also be focussed on the identification and treatment of iron deficiency anaemia in pregnancy and reducing errors in relation to anti-D prophylaxis.
• The Blood Safety and Quality Regulations (2005) put additional requirements on transfusion services for transfusion safety and quality, and these are currently monitored by the Medicines and Healthcare products Regulatory Agency (MHRA).
• An evidence-base for appropriate transfusion is starting to emerge, but there is a need for more and better clinical research to underpin best clinical practice guidelines.
ACTION
• This guidance is addressed to all NHS Trusts providing blood transfusion and managing patients who may need transfusion
• Primary Care Trusts (PCTs) and acute NHS Trusts should work together to implement the Better Blood Transfusion action plan
• NHS acute Trust Boards should formally review arrangements for Better Blood Transfusion and the appropriate use of blood at least annually
• Strategic Health Authorities have an important role to play in ensuring arrangements are in place for delivery
• NHS Blood and Transplant (NHSBT) has an important supporting role in the implementation of the Better Blood Transfusion action plan
Progress is expected in all areas by November 2008, when the first national audit of compliance will be undertaken. Annual audits will be conducted thereafter until 2012.
GUIDANCE
• Foundation Trusts are advised to take note of the contents of this HSC. An HTC should:
• Promote safe and appropriate blood transfusion practice through local protocols based on national guidelines
• Audit the practice of blood transfusion against the NHS Trust policy and national guidelines, focusing on critical points for patient safety and the appropriate use of blood
• Lead multi-professional audit of the use of blood within the NHS Trust, focusing on specialities where demand is high, including medical as well as surgical specialities, and the use of platelets, plasma, and other blood components as well as red cells
• Regularly review and take appropriate action on data on blood stock management, wastage and blood utilisation provided by the Blood Stocks Management Scheme (BSMS) and other sources
• Provide feedback on audit of transfusion practice and the use of blood to all NHS Trust staff involved in blood transfusion
• Develop and implement a strategy for the education and training for all clinical, laboratory and support staff involved in blood transfusion
• Promote patient education and information on blood transfusion including the risks of transfusion, blood avoidance strategies and the need to be correctly identified at all stages in the transfusion process
• Modify and improve blood transfusion protocols and clinical practice based on new guidance and evidence
• Be a focus for local contingency planning for and management of blood shortages
• Report regularly to Regional Transfusion Committees (RTC), and through them, to the National Blood Transfusion Committee (NBTC)
• Participate in the activities of the RTCs
• Consult with local patient representative groups where appropriate
• Contribute to the development of clinical governance 2. NHS Trusts involved in blood transfusion should implement arrangements for promoting good transfusion practice through the development of an effective clinical infrastructure, including the establishment of a HTT. The HTT should consist of:
• Lead consultant for transfusion (with funded sessions dedicated to blood transfusion), • Hospital transfusion practitioners or equivalent (e.g. nurses, biomedical scientists, medical professionals); the number of these staff depending on the size of the NHS Trust, • Blood transfusion laboratory manager, • Other members of the HTC can be co-opted.
There should be identified clerical, technical, managerial and information technology support as required, and access to audit and training resources to promote and monitor the safe and effective use of blood and alternatives to blood transfusion.
The role of the HTT is to:
• Implement the HTCs objectives
• Promote and provide advice and support to clinical teams on the safe and appropriate use of blood
• Promote patient information and education on blood transfusion safety and use of alternatives
• Actively promote the implementation of good transfusion practice
• Be a source for training all NHS Trust staff involved in the process of blood transfusion
• Produce an annual report including its achievements, action plan and resource requirements for consideration by senior management at Board level through the HTC and the Trust's clinical governance and risk management arrangements 3. Large NHS Trusts or Trusts with more than one site will need to ensure they have adequate staffing of the HTT to ensure that good transfusion practice is implemented in all clinical areas. Further information on the roles of the members of the HTT will be made available through the Better Blood Transfusion website.
4.
If a HTC or HTT and its members cover more than one NHS Trust, arrangements should be in place to ensure that there is sufficient cross-Trust representation. Trusts should also ensure that there are adequate resources and mechanisms for ensuring the safe, effective and appropriate use of blood at all the Trust sites involved in blood transfusion.
5.
HTCs should implement good transfusion practice through NHS Trusts' frameworks for clinical governance, performance and risk management, and compliance with NHS Litigation Authority (NHSLA) standards for Trusts and Clinical Pathology Accreditation (CPA) standards, and the requirements of the Medicines and Healthcare products Regulatory Authority (MHRA) and the National Patient Safety Agency (NPSA).
6.
Senior NHS Trust management should be represented on the HTC. There should be HTC representation on the NHS Trust's clinical governance/risk management committee, and the Chair of the HTC should be invited to present an annual report on blood transfusion.
7.
HTCs should work in a partnership with blood users, Blood Services and patients to improve the safety and appropriateness of blood transfusion.
8.
HTCs should participate in the activities of the RTCs and the NBTC for implementing and monitoring good transfusion practice.
Training and Education
9.
NHS Trusts should provide regular documented training and competency assessment in safe and appropriate transfusion practice for all staff involved in the transfusion process from blood sample collection to blood administration and the monitoring of patients during transfusion episodes (including phlebotomists, laboratory staff, porters, nurses and medical staff) in line with national guidelines and the NPSA's Safer Practice Notice (SPN) Right Patient -Right Blood (www.npsa.nhs.uk/health/display?contentId=5354). Examples of training modules and how they may be accessed will be made available through the Better Blood Transfusion website.
10. NHS Trusts should ensure that blood transfusion is included in clinical multidisciplinary audit and Continuous Professional Development (CPD) programmes for NHS Trust staff.
11. NHS Trusts should ensure that blood transfusion is included in the induction and orientation programmes for all relevant new staff.
Patient Information
12.
NHS Trusts should provide timely written information about blood transfusion and its alternatives, wherever possible, to patients at risk of a blood transfusion. Patients should be encouraged to ask questions about blood transfusion.
Under medical law, healthcare providers must warn patients of the risk of variant Creutzfeldt-Jakob Disease (vCJD) infection through transfusion if this is regarded as a significant risk so that the patient can determine for him or herself whether to receive the transfusion. If the healthcare worker has not warned the patient of this risk, and the patient then goes on to develop vCJD, the patient could bring a successful claim in damages.
In addition, patients should be made aware of the importance of iron deficiency and its correction in relation to transfusion avoidance in pregnancy and surgery. Patients should also be informed of the option of cell salvage where appropriate.
13. National leaflets can be used and adapted for local use. An example of these and contacts for examples of leaflets for specific patient groups will be made available through the NHSBT Hospitals and Science website www.hospital.blood.co.uk
14.
The NBTC is promoting strategies for national patient transfusion awareness aimed at involving patients and the public in blood transfusion. Various promotional material including posters and leaflets are available through the Better Blood Transfusion Toolkit section of the www.transfusionguidelines.org.uk website.
Guidelines for Good Practice and Standards
15.
NHS Trusts should have agreed and disseminated protocols for safe and appropriate transfusion practice, based on national guidelines and supported by in-house training. Guidelines should include the indications for transfusion, the complete transfusion process from blood sample collection to its administration, the monitoring required during transfusion, and the documentation required in the clinical records.
16.
Trusts should adopt national guidelines for the appropriate use of blood.
17.
The following national guidelines and websites for the safe, effective and appropriate use of blood are recommended to all NHS Trusts. These and additional guidelines, where available electronically, will be linked through the Better Blood Transfusion website www.transfusionguidelines.org.uk.
• 
Better Blood Transfusion Toolkit
32.
A toolkit to assist NHS Trusts in the implementation of the actions outlined in this Health Service Circular (HSC) can be found on the www.transfusionguidelines.org.uk website. It provides access to national guidance, examples of good practice, and is regularly updated.
Regional and National Transfusion Committees
33.
The overall objective of the NBTC and the RTCs is to promote safe and appropriate transfusion practice in accordance with the Better Blood Transfusion initiative and with the action plan in this HSC.
34.
The committees provide a framework to channel information and advice to hospitals on best practice and performance monitoring. The RTCs support the activities of the HTCs and HTTs within their region. Further information about the activities of these committees is available on the NBTC and RTCs section of the www.transfusionguidelines.org.uk website. 
NHS Blood and Transplant
Recommendations requiring further work
37.
The need for further work to support the Better Blood Transfusion initiative was highlighted at the CMOs' Seminar. Several of the following areas are already in initial development and will be placed on the Better Blood Transfusion Toolkit when progressed.
• Explore the application of new techniques to improve the safety and effectiveness of transfusion practice
• Development of electronic systems to improve the safety of blood transfusion and to monitor the appropriate use of blood. Examples of progress in this area is available on the Better Blood Transfusion (www.transfusionguidelines.org.uk) website
• Revision of a tool for accessing the 'resources' required to implement Better Blood Transfusion at Trust level (e.g. the make-up in 'sessional' time of a HTT and the required supporting services)
• Ensure prompt evaluation and implementation of new technologies for fetal RhD typing from maternal blood to reduce unnecessary routine anti-D prophylaxis
• Development of national training and educational materials, including elearning programmes
• Continued development of patient information leaflets and transfusion awareness tools
• The development of performance standards for aspects of transfusion safety in hospitals e.g. blood sample collection and pre-transfusion bedside checking
• Commissioning of high quality clinical research (systematic reviews and clinical trials) on safe and effective transfusion practice including the alternatives to blood transfusion
• Further work to prevent transfusion laboratory errors, as highlighted by successive SHOT reports
